nach oben

World Journal of Surgery

Erschienen in:

01.07.2012

Breast Cancer Local Therapy: What Is Its Effect on Mortality?

verfasst von: John R. Benson, Katy A. T. Teo

Erschienen in: World Journal of Surgery | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Until recently, the concept of biological predeterminism appeared pre-eminent and a worthy successor to the Halstedian doctrine of centrifugal spread of cancer. However, evidence has now emerged from clinical trials to cast doubt on the universal application of this concept to breast tumors. Prevention of local recurrence can save lives, local control does matter, and rates of local recurrence should be minimized in the first 5 years. In up to one quarter of cases of local recurrence the locally recurring disease will be a determinant and not simply a marker of risk for distant relapse and death. Both types of local recurrence are manifestations of the same biological processes and reflect intrinsic behavior of the tumor. This principle applies to reduction in local relapse from both adjuvant radiotherapy and surgical modalities.

Fisher B, Anderson S, Fisher ER et al (1991) Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 338:327–331PubMedCrossRef

Veronesi U, Marubini E, Del Vecchio M et al (1995) Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 87:19–27PubMedCrossRef

Komoike Y, Akiyama F, Lino Y et al (2005) Ipsilateral breast tumour recurrence (IBTR) after breast conserving treatment for breast cancer. Cancer 106:35–39CrossRef

Wapnir IL, Anderson SJ, Mamounas EP et al (2006) Prognosis after ipsilateral breast tumour recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 24:2028–2036PubMedCrossRef

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview of the randomized trials. Lancet 366:2087–2106

Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752PubMedCrossRef

Halsted WS (1898) The results of radical operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Ann Surg 20:455–497

Hellman S (1994) Natural history of small breast cancers. J Clin Oncol 12:2229–2234PubMed

Rosen PP, Groshen S, Saigo PE et al (1989) A long term follow up study of survival in stage I (T1M0) and stage II (T1N1) breast carcinoma. J Clin Oncol 7:355–366PubMed

10.

Cancer Research UK. Available at: http://info.cancerresearchuk.or/cancerstats. Accessed Mar 2011

11.

Urban JA (1952) Radical mastectomy in continuity with en bloc resection of the internal mammary lymph node chain. Cancer 5:992–1008PubMedCrossRef

12.

Veronesi U, Marubini E, Mariani L et al (1999) The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30 Year results of a randomized trial. Eur J Cancer 35:1320–1325PubMedCrossRef

13.

Gotzsche PC, Nielsen M (2006) Screening for breast cancer with mammography. Cochrane Database Syst Rev 3:CD 001877h

14.

Berry DA, Cronin KA, Plevritis SK et al (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Eng J Med 353:1784–1792CrossRef

15.

Kalager M, Zelen M, Langmark F et al (2010) Effect of screening mammography on breast cancer mortality in Norway. N Engl J Med 363:1203–1210PubMedCrossRef

16.

Baum M, Benson JR (1996) Current and future roles of adjuvant endocrine therapy in management of early carcinoma of the breast. Recent Results Cancer Res 140:215–226PubMed

17.

Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMedCrossRef

18.

Haffty BG, Reiss M, Beinfield M et al (1996) Ipsilateral breast tumour recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. J Clin Oncol 14:52–57PubMed

19.

Komoike Y, Akiyama F, Iino Y et al (2006) Ipsilateral breast tumour recurrence (IBTR) after breast conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer 106:35–41PubMedCrossRef

20.

Benson JR, della Rovere GQ (2008) Ipsilateral breast cancer recurrence. Breast 17:12–18PubMedCrossRef

21.

Fisher B, Joeng J-H, Anderson S et al (2002) Twenty-five year follow up of a randomized trial comparing radical mastectomy, total mastectomy and total mastectomy followed by irradiation. N Engl J Med 347:567–575PubMedCrossRef

22.

Overgaard M, Hansen PS, Overgaard J et al (1997) Post-operative radiotherapy in high risk pre-menopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337:949–955PubMedCrossRef

23.

Ragaz J, Jackson SM, Le N et al (1997) Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956–962PubMedCrossRef

24.

Vinn-Hung V, Verschraegen C (2004) Breast conserving surgery with or without radiotherapy: pooled analysis for risks of ipsilateral breast tumour recurrence and mortality. J Natl Cancer Inst 96:115–121CrossRef

25.

Whelan TJ, Lada BM, Laukkanen E et al (1997) Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group. Cancer Prev Control 1:228–240PubMed

26.

Early Breast Cancer Trialists’ Collaborative Group (2000) Favourable and unfavourable effects on long-term survival for early breast cancer: an overview of the randomized trials. Lancet 355:1757–1770

27.

Vinh-Hung V, Burzykowski T, Van de Steene J et al (2002) Post-surgery radiation in early breast cancer: survival analysis of registry data. Radiother Oncol 64:281–290PubMedCrossRef

28.

Kyndi M, Overgaard M, Nielsen HM et al (2009) High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c. Radiother Oncol 90:74–79PubMedCrossRef

29.

The Supremo Trial (2011) Available at www.supremo-trial.com. Accessed Mar 2011

30.

Demechelli R, Valagussa P, Bonadonna G (2002) Double peaked time distribution of mortality of breast cancer patients undergoing mastectomy. Breast Cancer Res Treat 75:127–134CrossRef

31.

Fortin A, Larochelle M, Laverdiere J et al (1999) Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol 17:101–109PubMed

32.

Benson JR, Querci della Rovere G (2002) Ipsilateral local recurrence of breast cancer: determinant or indicator of poor prognosis? Lancet Oncol 3:183–187PubMedCrossRef

33.

Hellman S (1997) Stopping metastases at their source. N Engl J Med 337:996–997PubMedCrossRef

34.

Paik S, Shak S, Tang G et al (2004) A multigene assay to predict recurrence of tamoxifen treated, node negative breast cancer. N Engl J Med 351:2817–2826PubMedCrossRef

35.

Locker G, Sainsbury R, Cuzick J (2002) Breast surgery in the ATAC trial: women in the United States are more likely to have mastectomy. Breast Cancer Res Treat 76:S35

36.

Schnitt SJ, Abner A, Gelman R et al (1994) The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 74:1746–1751PubMedCrossRef

37.

Ryoo MC, Kagan AT, Wollin M et al (1989) Prognostic factors for recurrence and cosmesis in 393 patients after radiation therapy for early mammary carcinoma. Radiology 172:555–559PubMed

38.

Kurtz JM, Jacquemir J, Amalric R et al (1990) Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer 65:1867–1878PubMedCrossRef

39.

Boger J, Kemperman H, Hart A et al (1994) Risk factors in breast conservation therapy. J Clin Oncol 12:653–660

40.

Di Biase S, Komarnicky LT, Schwartz GF et al (1988) The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma. Cancer 82:2212–2220

41.

Schmidt-Ulrich R, Wazer D, Tercilla O et al (1989) Tumour margin assessment as a guide to optimal conservation surgery and irradiation in early-stage breast carcinoma. Int J Radiat Oncol Biol Phys 17:733–738CrossRef

42.

Solin LJ, Fowble BL, Schultz DJ et al (1991) The significance of the pathology margins of the tumour excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 21:279–287PubMedCrossRef

43.

Schnitt SJ (2003) Risk factors for local recurrence in patients with invasive breast cancer and negative surgical margins of excision. Am J Clin Pathol 120:485–488PubMedCrossRef

44.

Mirza NQ, Vlastos G, Meric F et al (2002) Predictors of loco-regional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol 9:256–265PubMedCrossRef

45.

Wallgren A, Bonetti M, Gelber RD et al (2003) Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII. J Clin Oncol 21:1205–1213PubMedCrossRef

46.

Park CC, Mitsumori M, Nixon A et al (2000) Outcome at 8 years after breast conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18:1668–1675PubMed

47.

Sanghani M, Truong PT, Taad RA et al (2010) Validation of a web-based predictive nomogram for ipsilateral breast tumour recurrence after breast conservation treatment. J Clin Oncol 28:718–722PubMedCrossRef

48.

Kyndi M, Sorensen FB, Knudsen H et al (2008) Estrogen receptor, progesterone receptor, HER2 and response to postmastectomy radiotherapy in high risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol 26:1419–1426PubMedCrossRef

49.

Nguyen PL, Taghian AG, Katz MS et al (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor and HER2 is associated with local and distant recurrence after breast conserving therapy. J Clin Oncol 26:2373–2378PubMedCrossRef

50.

Smitt MC, Nowels K, Carlson RW et al (2003) Predictors of re-excision findings and recurrence after breast conservation. Int J Radiat Oncol Biol Phys 57:979–985PubMedCrossRef

51.

Petersen ME, Schultz DJ, Reynolds C et al (1999) Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 43:1029–1035CrossRef

52.

Wazer DE, Schmidt-Ulrich RK, Ruthazer R et al (1998) Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumour bed. Int J Radiat Oncol Biol Phys 40:851–858PubMedCrossRef

53.

Freedman G, Fowble B, Hanlon A et al (1999) Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 44:1005–1015PubMedCrossRef

54.

Taghian A, Mohiuddin M, Jagsi R et al (2005) Current perceptions regarding surgical margin status after breast conserving therapy: results of a survey. Ann Surg 241:629–639PubMedCrossRef

55.

Young OE, Valassiadou K, Dixon M (2007) A review of current practices in breast conservation surgery in the UK. Surg Oncol 89:118–123

56.

Ward ST, Jones BG, Jewkes AJ (2010) A two millimeter free margin from invasive tumour minimizes residual disease in breast conserving surgery. Int J Clin Pract 64:1675–1680PubMedCrossRef

57.

Moore MM, Borossa G, Imbrie JZ et al (2000) Association of infiltrating lobular carcinoma with positive surgical margins after breast conservation therapy. Ann Surg 231:877–882PubMedCrossRef

58.

Dillon MF, Hill AD, Fleming FJ et al (2006) Identifying patients at risk of compromising margins following breast conservation for lobular carcinoma. Am J Surg 191:201–205PubMedCrossRef

59.

Dillon MF, Hill ADK, Quinn CM et al (2006) A pathological assessment of adequate margin status in breast conserving surgery. Ann Surg Oncol 13:333–339PubMedCrossRef

60.

Liau S-S, Cariati M, Noble D et al (2010) Audit of local recurrence following breast conservation surgery with 5 mm target margin and 40-gray breast radiotherapy for invasive breast cancer. Ann R Coll Surg Engl 92:562–568PubMedCrossRef

61.

Morrow M, Schmidt R, Hassett C (1995) Patient selection for breast conservation therapy with magnification mammography. Surgery 118:621–626PubMedCrossRef

62.

Pittinger TP, Maronian NC, Poulter CA et al (1994) Importance of margin status in outcome of breast conserving surgery for carcinoma. Surgery 116:605–609PubMed

63.

Forouhi P, Brahmbhatt DH, Benson JR et al. (2009) Breast conservation: factors predictive of residual disease following reoperation for narrow surgical margins. Cancer Res 69(Suppl 1)

64.

Singletary SE (2002) Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 184:383–393PubMedCrossRef

65.

Morrow M, Harris JR (2007) Practice guidelines for breast conserving therapy in the management of invasive breast cancer. J Am Coll Surg 205:362–376CrossRef

66.

Silverstein M, Lagios M, Groshen S et al (1999) The influence of margin width on local control of ductal carcinoma of the breast. N Engl J Med 340:1455–1461PubMedCrossRef

67.

Dunne C, Burke JP, Morrow M et al (2009) Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 27:1615–1620PubMedCrossRef

68.

NICE Clinical Guideline 80 (2009) Early and locally advanced breast cancer: diagnosis and treatment

69.

Veronesi U, Volterrani F, Luini A et al (1990) Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 26:671–673PubMedCrossRef

70.

Asgeirsson K, McCulley S, Pinder S et al (2003) Size of invasive breast cancer and risk of local recurrence after breast conserving therapy. Eu J Cancer 39:2462–2469CrossRef

71.

Van Dongen JA, Bartelink H, Fentimen I et al (1992) Factors influencing local relapse and survival and results of salvage treatment after breast conserving treatment in operable breast cancer. Eu J Cancer 28A:808–815

72.

Fisher BJ, Perera FE, Cooke AL et al (1997) Long term follow up of axillary node positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence. Int J Radiat Oncol Biol Phys 38:541–550PubMedCrossRef

73.

Clough KB, Lewis JS, Couturaud B et al (2003) Oncoplastic techniques allow extensive resection for breast conserving therapy of breast carcinomas. Ann Surg 237:26–34PubMedCrossRef

74.

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15 year survival: an overview of the randomized trials. Lancet 365:1687–1717CrossRef

75.

Mamounas EP, Tang G, Fisher B et al (2010) Association between the 21-gene recurrence score assay and risk of loco-regional recurrence in node negative estrogen receptor positive breast cancer: results from NSABP B-14 and NSABP B-20. J Clin Oncol 28:1677–1683PubMedCrossRef

76.

Giuliano AE, Hunt K, Ballman K et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastases: a randomized clinical trial. JAMA 305:569–575PubMedCrossRef

Titel: Breast Cancer Local Therapy: What Is Its Effect on Mortality?
verfasst von: John R. Benson
Katy A. T. Teo
Publikationsdatum: 01.07.2012
Verlag: Springer-Verlag
Erschienen in: World Journal of Surgery / Ausgabe 7/2012
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-012-1468-5

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2012

The Distribution of Survival Times after Injury

Laparoscopic Appendectomy Outcomes on the Weekend and During the Week are no Different: A National Study of 151,774 Patients

Rate of Clinically Significant Postoperative Pancreatic Fistula in Pancreatic Neuroendocrine Tumors

Update on Breast Reconstruction Techniques and Indications

Verification of Early Removal of the Chest Tube after Absorbable Mesh-based Pneumostasis Subsequent to Video-assisted Major Lung Resection for Cancer

Evaluation of the Appendicitis Inflammatory Response Score for Patients with Acute Appendicitis

Update Chirurgie